Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1987-5-4
pubmed:abstractText
Progressive inhibition of tissue factor activity occurs upon its addition to human plasma (serum). This process requires the presence of factor VII(a), facto-X(a), Ca2+, and another component in plasma that we have called the tissue factor inhibitor (TFI). A TFI secreted by HepG2 cells (human hepatoma cell line) was isolated from serum-free conditioned medium in a four-step procedure including CdCl2 precipitation, diisopropylphosphoryl-factor Xa affinity chromatography, Sephadex G-75 superfine gel filtration, and Mono Q ion-exchange chromatography. The purified TFI contained a predominant band at Mr 38,000 on NaDodSO4/polyacrylamide gel electrophoresis that comigrates with inhibitory activity. Like the activity present in plasma, this TFI requires the presence of factor VII(a), factor X(a), and Ca2+ to express inhibitory activity. Its specific activity (assuming an extinction coefficient of 10 at 280 nM, for a 1-cm path length through a 1% solution) was 9800 units/mg of protein, where 1 unit of TFI activity was defined as that present in 1 ml of normal pooled serum.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-13052697, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-190271, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-2995451, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-3024756, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-3087014, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-3487091, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-3873968, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-3965464, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-47334, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-4942184, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-6332168, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-6795061, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-7312833, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-7354023, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-7380833, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-762243, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-884317, http://linkedlifedata.com/resource/pubmed/commentcorrection/3031657-925006
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1886-90
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't